BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38146079)

  • 1. Characterization of circulating miRNAs in the treatment of primary liver tumors.
    Umezu T; Tanaka S; Kubo S; Enomoto M; Tamori A; Ochiya T; Taguchi YH; Kuroda M; Murakami Y
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1964. PubMed ID: 38146079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
    Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
    J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches.
    Badami E; Busà R; Douradinha B; Russelli G; Miceli V; Gallo A; Zito G; Conaldi PG; Iannolo G
    World J Gastroenterol; 2022 Jun; 28(22):2417-2428. PubMed ID: 35979260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma.
    Shabangu CS; Su WH; Li CY; Yu ML; Dai CY; Huang JF; Chuang WL; Wang SC
    J Transl Med; 2024 Mar; 22(1):268. PubMed ID: 38475805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma.
    Weis A; Marquart L; Calvopina DA; Genz B; Ramm GA; Skoien R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC).
    Shehab-Eldeen S; Nada A; Abou-Elela D; El-Naidany S; Arafat E; Omar T
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2515-2522. PubMed ID: 31450927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of circulating microRNA-21 and microRNA-215 in the diagnosis of hepatitis C related hepatocellular carcinoma.
    Abdelkhalek ZS; Abdalla MS; Fathy MM; Elbaz TM; Abdelaziz AO; Nabeel MM; Shousha HI; Kamel AH; Kamel MH
    J Infect Dev Ctries; 2021 Jul; 15(7):997-1003. PubMed ID: 34343125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinoma.
    Shaker O; Alhelf M; Morcos G; Elsharkawy A
    Infect Genet Evol; 2017 Jul; 51():173-181. PubMed ID: 28366737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus.
    Takeda H; Takai A; Iguchi E; Mishima M; Arasawa S; Kumagai K; Eso Y; Shimizu T; Takahashi K; Ueda Y; Taura K; Hatano E; Iijima H; Aoyagi H; Aizaki H; Marusawa H; Wakita T; Seno H
    Carcinogenesis; 2021 May; 42(5):672-684. PubMed ID: 33617626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitinase 3-like-1, Tolloid-like protein 1, and intergenic gene polymorphisms are predictors for hepatocellular carcinoma development after hepatitis C virus eradication by direct-acting antivirals.
    Mangoud NOM; Ali SA; El Kassas M; Soror SH
    IUBMB Life; 2021 Feb; 73(2):474-482. PubMed ID: 33347699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
    Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miRNA Panel in Egyptian Patients with Chronic Hepatitis C Related Hepatocellular Carcinoma.
    Khairy A; Hamza I; Shaker O; Yosry A
    Asian Pac J Cancer Prev; 2016; 17(5):2699-703. PubMed ID: 27268654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
    Fouda MS; Omran MM; Tarek G; Hady A Abdel Wahab A
    Arab J Gastroenterol; 2021 Mar; 22(1):28-33. PubMed ID: 33268243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly Sensitive Serum miRNA Panel for the Diagnosis of Hepatocellular Carcinoma in Egyptian Patients with HCV-Related HCC.
    Yosry A; Zayed N; Dawood RM; Ibrahim MK; Elsharkawy M; Ekladious SM; Khairy A; Elsharkawy A; Khairy M; Abdel Alem S; Bader El Din NG; El Awady MK; Abdellatif Z
    Lab Med; 2022 Sep; 53(5):523-529. PubMed ID: 35731638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of circulating microRNAs for hepatitis C virus-associated hepatocellular carcinoma: a systematic review and meta-analysis.
    Huang Y; Chen Y; Tu S; Zhang J; Qiu Y; Yu W
    BMC Infect Dis; 2022 Apr; 22(1):323. PubMed ID: 35365115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma.
    Boonkaew B; Satthawiwat N; Pinjaroen N; Chuaypen N; Tangkijvanich P
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.
    Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P
    Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.